gastric cancer
NICE recommends pembrolizumab for advanced stomach cancers
Posted in Medicine on 27th Aug, 2024
by Alex Muller
NICE has approved pembrolizumab for advanced gastric cancer, enhancing survival and delaying progression when combined with chemotherapy.